Clinical Trials Sponsored by RPH Central Pharma

Total 325 results

D'Or Institute for Research and Education
Bayer; RPH Central Pharma

Recruiting

A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer

Prostate Cancer

Brazil
pH Pharma

Not yet recruiting

A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Primary Open Angle Glaucoma | Ocular Hypertension

Korea, Republic of
pH Pharma

Completed

A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of PHP-303 in Otherwise Healthy Overweight or Obese Subjects

Otherwise Healthy Overweight or Obese

United States
pH Pharma

Completed

Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma

Normal Tension Glaucoma

Korea, Republic of
pH Pharma

Completed

A Study of Safety, Tolerability, and Pharmacokinetics of Single Doses of PHP-303 in Healthy Subjects

Healthy Volunteer

United States
pH Pharma

Completed

PK/PD, Safety and Tolerability of PHP-201 Topical Eye Drop in Korean and Japanese Healthy Subjects

Healthy Volunteer

Korea, Republic of
Theodore R. Brown, MD MPH
Astellas Pharma Inc

Completed

Study of Behavioral Modification Program and Mirabegron to Improve Urinary Urgency in Multiple Sclerosis (MIRROR)

Multiple Sclerosis

United States
Central Hospital, Nancy, France
UCB Pharma

Not yet recruiting

Digital Solution to Improve Cognitive Function in Epilepsy: PRODDIGE Project (PRODDIGE)

Cognitive Change
Massachusetts General Hospital
UCB Pharma

Withdrawn

Seizure Therapy With Intravenous Levetiracetam and Lorazepam (STILL)

Seizures
Centre Leon Berard
NETRIS Pharma

Completed

First in Human Evaluation of Safety, Pharmacokinetics, and Clinical Activity of a Monoclonal Antibody Targeting Netrin 1 in Patients With Advanced/Metastatic Solid Tumors (NP137)

Advanced Solid Tumor | Endometrial Carcinoma | Hormone Receptor Positive

France
Centre Leon Berard
NETRIS Pharma

Recruiting

Acute Myeloid Leukemia Treated With With NETrin Abs in Combination With [AZACITIDINE + VENETOCLAX] (AML-NET)

Acute Myeloid Leukemia Refractory

France
Centre Leon Berard
NETRIS Pharma

Recruiting

NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies (IMMUNONET)

Advanced Solid Tumors | Metastatic Solid Tumors

France
ERYtech Pharma
Centre Leon Berard

Completed

Administration of Allogenic Red Blood Cells Loaded L-asparaginase in Cases of Relapse of Acute Lymphoblastic Leukaemia (GRASPALL)

Acute Lymphoblastic Leukemia

France
Kyle Staller, MD, MPH
Ardelyx

Recruiting

Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation

IBS - Irritable Bowel Syndrome | IBS

United States
Dr Cipto Mangunkusumo General Hospital
Astellas Pharma Indonesia Inc.; Pharos Life Corporation

Unknown

The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females

Urinary Tract Infection

Indonesia
University of Manitoba
Victoria General Hospital Foundation; Reh-Fit Fitness Centre; Wellness Institute-Seven...

Withdrawn

For Her Heart's Sake STEP Project: A Clinical Trial (FHHS: STEP)

Cardiovascular Diseases
Massachusetts General Hospital
Astellas Pharma Inc

Completed

A Pilot Study Evaluating the Usability of the Oabi Mobile Application (OAB)

Overactive Bladder

United States
Centre Hospitalier Universitaire, Amiens
Roche Pharma AG; Astellas Pharma Inc

Completed

TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic

Kidney Transplantation

France
Massachusetts General Hospital
Astellas Pharma Inc

Completed

Myocardial Stress Perfusion Imaging With Dual Source CT

Coronary Artery Disease

United States
Centre Francois Baclesse
Roche Pharma AG

Completed

Optimize the Requirements and Preparations in Outpatient Chemotherapy

Cancer | IV Anticancer Therapy

France
Centre Leon Berard
Roche Pharma AG

Recruiting

Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy (RT-Immune)

Sarcoma,Soft Tissue

France, United Kingdom
Centre Leon Berard
Roche Pharma AG

Completed

Evaluation of the Added Value of a Large Molecular Profiling Panel Versus a Limited Molecular Profiling Panel in Advanced Solid Tumors. (PROFILER 02)

Advanced Solid Tumor

France
Centre Oscar Lambret
Roche Pharma AG

Completed

Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors (DIPROCOL)

Metastatic Colorectal Cancer | Non-Small-Cell Lung Carcinoma

France
Centre Hospitalier Universitaire Vaudois
Advicenne Pharma

Completed

Pharmacokinetics and Tolerability of Sulthiame

Epilepsy

Switzerland
Centro Regional para el Estudio de las Enfermedades...
MERZ PHARMA

Completed

Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.

Hepatic Encephalopathy

Mexico
Psoriasis Treatment Center of Central New Jersey
LEO Pharma

Completed

Enstilar in Combination With Biologic Agents

Psoriasis

United States
Psoriasis Treatment Center of Central New Jersey
LEO Pharma

Unknown

Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis

Psoriasis

United States
Sumitomo Pharma (Suzhou) Co., Ltd.
Xuhui Central Hospital, Shanghai

Completed

A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects

Schizophrenia

China
Jeffrey Jenks, MD, MPH
Astellas Pharma Global Development, Inc.

Terminated

Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis (Isavu-CAPA)

Severe Acute Respiratory Syndrome Coronavirus 2 | Aspergillosis Invasive

United States
Sumitomo Pharma (Suzhou) Co., Ltd.
Xuhui Central Hospital, Shanghai

Completed

Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects

Schizophrenia

China
Chinese PLA General Hospital
Roche Pharma AG

Completed

Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

Malignant Pleural Effusion

China
Centre Hospitalier Universitaire, Amiens
Roche Pharma AG

Completed

Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant (Neo-PDGF)

Kidney Failure

France
Centre Hospitalier Universitaire, Amiens
Roche Pharma AG

Completed

Correction of Anaemia and Progression of Renal Failure on Transplanted Patients

Kidney Failure | Renal Transplantation | Anaemia

France
Centre Hospitalier St Anne
Roche Pharma AG

Not yet recruiting

Impact of Microglial Activation on Synaptic Density in Alzheimer's Disease (GliSyn)

Alzheimer Disease

France
Centre Hospitalier Universitaire de Nīmes
Pherecydes Pharma

Not yet recruiting

Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus (PhagoPied)

Diabetic Foot | Staphylococcal Infections

France
Centro Cardiologico Monzino
Orion Corporation, Orion Pharma

Completed

Levosimendan Efficacy Assessment by Cardiopulmonary Exercise Test (CPET)

Heart Failure

Italy
VieCuri Medical Centre
Orion Corporation, Orion Pharma

Unknown

Levosimendan in Acute Kidney Injury Study (LAKIS)

Acute Kidney Injury

Netherlands
Sinew Pharma Inc.
Taipei Veterans General Hospital, Taiwan

Recruiting

To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen Overdose

Hepatitis

Taiwan
Mitsubishi Tanabe Pharma America Inc.
Massachusetts General Hospital

Active, not recruiting

Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)

Amyotrophic Lateral Sclerosis | ALS

United States, Canada
Zealand Pharma
Massachusetts General Hospital; Beta Bionics, Inc.

Completed

Feasibility Trial Testing the Bionic Pancreas With ZP4207 (dasiglucagon)

Diabetes Mellitus, Type 1

United States
Massachusetts General Hospital
Zealand Pharma; Beta Bionics, Inc.

Completed

The Bihormonal iLet Bionic Pancreas Feasibility Study

Type 1 Diabetes Mellitus

United States
Hospital General Universitario Gregorio Marañon
Roche Pharma AG

Unknown

Reduced Ultrasound Counts in Rheumatoid Arthritis

Rheumatoid Arthritis

Spain
Hospital General de México Dr. Eduardo Liceaga
National Polytechnic Institute, Mexico; Italmex Pharma; Medix Farma

Unknown

Probiotics on Body Composition and Insulin Resistance in Patients With Obesity and Its Association With Gut Microbiota

Obesity | Insulin Resistance | Microbial Colonization

Mexico
Centre Hospitalier Universitaire de Saint Etienne
LEO Pharma

Completed

Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer (METRO B)

Lymphoma | Multiple Myeloma

France
Axoltis Pharma
Centre for Human Drug Research, Netherlands

Recruiting

MAD Study of NX210c (CHDR2235)

Healthy Elderly

Netherlands
Centre Hospitalier Universitaire de Nīmes
Roche Pharma AG

Completed

Evaluation of an Automatic Segmentation Software (Pixyl.Neuro) to Track Lesions in Multiple Sclerosis Patients Via Cerebral MRI (PIXCIS)

Multiple Sclerosis | Clinically Isolated Syndrome

France
Centro Hospitalar Lisboa Ocidental
Orion Corporation, Orion Pharma

Completed

Subsyndromal Delirium in Intensive Care Unit (SubSynD)

Delirium

Portugal
Centre Antoine Lacassagne
Roche Pharma AG; Centre Hospitalier Universitaire de Caen

Recruiting

Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc) (Stereosarc)

Sarcoma | Radiosurgery

France
John Winkelman, MD, PhD
UCB Pharma

Completed

Switching From Oral Dopamine Agonists to Rotigotine (SWITCH)

Restless Legs Syndrome | Ekbom Syndrome | Willis-Ekbom Disease

United States
Jacob Soumerai, MD
MEI Pharma, Inc.

Withdrawn

Zandelisib + Tazemetostat in R/R Follicular Lymphoma

Relapsed Follicular Lymphoma | Refractory Follicular Lymphoma

United States

Clinical Trials Sponsored by RPH Central Pharma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations